Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Emory University
With
Emmaus Medical, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patients (≥ 18 years of age) with cystic fibrosis who give informed consent
Patients must have a clinically diagnosed pulmonary exacerbation at time of enrollment, characterized by clinical requirement for oral or intravenous antibiotics associated with pulmonary symptoms such as increased cough or decreased forced expiratory volumes (FEV1)
Participants must agree to provide phlebotomy samples and complete all study protocol at presentation and at return visits
You may not be if
Any patients taking specific glutamine supplements within 30 days of enrollment
Pregnant or lactating women
Patients involved in any other research protocol involving intake of a study drug, in the last 60 days.
Patients who are chronically immunosuppressed due to drugs or immunosuppressive illness other than CF (e.g. HIV/AIDS, chronic autoimmune disease)
Patients receiving hemodialysis or with creatinine \>2.5mg/dL
Patients with liver failure from any cause
Patients with a history of cancer within the past 12 months or currently receiving anti-neoplastic therapy.
